Nuvation Bio NUVB Operating Lease Liabilities (Total)

Operating Lease Liabilities (Total) at other companies

ImmunomeIMNM

$3.69M-22.6%

Inhibrx Biosciences, Inc.INBX

$5.9M-25.0%

ImmunityBio, Inc.IBRX

$40.77M+0.5%

Summit TherapeuticsSMMT

$20.89M+189%

FAQ

What is Nuvation Bio's operating lease liabilities (total)?

Nuvation Bio (NUVB) reported operating lease liabilities (total) of $3.63M in Q2 2026.

How has Nuvation Bio's operating lease liabilities (total) changed year-over-year?

Nuvation Bio's operating lease liabilities (total) decreased by 30.4% year-over-year, from $5.21M to $3.63M.

What is the long-term trend for Nuvation Bio's operating lease liabilities (total)?

Over 4 years (2021 to 2025), Nuvation Bio's operating lease liabilities (total) has grown at a 9.7% compound annual growth rate (CAGR), from $3.06M to $4.42M.

What does operating lease liabilities (total) mean?

This represents the total present value of future lease payments for operating leases, recognized as a liability on the balance sheet. It reflects the company's long-term commitment to leased assets such as office space, warehouses, and equipment. Tracking this helps investors evaluate the company's off-balance-sheet financing obligations and overall debt-like commitments.